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INTRODUCTION:  Choroidal  melanoma  is the most  common  primary  malignant  intraocular  tumor  in adults.
And  its  metastatic  spread  has  been  considered  to be hematogenous  with  the  liver being  the  most  common
site,  and a solitary  pulmonary  metastasis  without  hepatic  involvement  is quite  rare.
PRESENTATION OF  CASE: We  report  the  case  of  a  61-year-old  woman  with  a solitary  pulmonary  metastasis
from  choroidal  melanoma,  which  had  been  originally  treated  with enucleation  13 years  ago.  Video-
assisted  thoracoscopic  surgery  (VATS)  right  upper  lobectomy  was  performed  for  the  right  upper  lobehoroidal melanoma
etastases
olitary  pulmonary metastasis
ATS  (video-assisted thoracoscopic
urgery)
tumor,  which  was  histopathologically  conﬁrmed  to  be metastatic  choroidal  melanoma.
DISCUSSION: Our  case  is  quite  unusual  in  2 points;  ﬁrstly,  a solitary  pulmonary  metastasis  without  hepatic
involvement  is rare.  Secondly,  this  mode  of  metastasis  with  an  exceptionally  long  disease-free  period  (13
years)  is  also  rare.
CONCLUSION:  A  pulmonary  metastasis  from  choroidal  melanoma  is  described  with  reference  to relevant
literature.
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. Introduction
Melanoma of the choroid (which is part of the uvea) is an uncom-
on malignancy with a reported incidence of about 6 per million
opulation per year.1 Its diagnosis can be done non-invasively
ith indirect ophthalmoscopy (IO), A- and B-ultrasonography
cans, fundus ﬂuorescein angiography (FFA), and transillumination.
nvasive studies such as ﬁne needle aspiration are not routinely
ecommended due to its signiﬁcant complications like seeding of
umor cells in the needle track.2 Because of higher blood ﬂow of the
horoid, the mode of metastatic spread of choroidal melanoma has
een considered to be hematogenous with the liver being the most
ommon site.3 A solitary metastasis without hepatic involvement
s quite rare.
.  Presentation of caseA 61-year-old woman who had undergone left ocular enucle-
tion for choroid melanoma 13 years ago was referred to our
epartment for the evaluation of a solitary pulmonary tumor in the
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right upper lobe. The histopathological examination of the enu-
cleated left eye showed a mixed-cell-type choroidal melanoma
without intrascleral or vascular involvement. The size of the
melanoma was 10 mm in thickness and 13 mm  in diameter.
Since then, the patient had been followed up regularly by an
ophthalmologist. An abnormal shadow, which was incidentally
found on chest radiograph for a health screening, was con-
ﬁrmed to be a solitary nodule measuring 25 mm in diameter in
the right upper lobe by computed tomography (CT) scan. F-18-
ﬂuoro-2-deoxyglucose positron emission tomography/computed
tomography (FDG-PET/CT) scan demonstrated a solitary pul-
monary nodule with increased FDG uptake. For a diagnostic and
therapeutic purpose, video-assisted thoracoscopic surgery (VATS)
right upper lobectomy was performed with uneventful postopera-
tive recovery. Intraoperative gross examination revealed a black
tumor in the right upper lobe in the vicinity of the pulmonary hilum.
Histopathological examination of the tumor resected from the right
upper lobe revealed metastatic melanoma (Fig. 1).
3.  Discussion
Choroidal melanoma is the most common primary intraocular
malignancy in adults. In the general population, it is uncommon
with an incidence of 5.3–10.9 cases per million population per year;
both sexes are equally affected.1
Open access under CC BY-NC-ND license.A small choroidal melanoma (longitudinal diameter 1–3 mm,
anterior-posterior diameter ≥5 mm)  in the posterior fundus is
amenable to several treatment options, including laser photo-
coagulation, photodynamic therapy, plaque radiation therapy,
s Ltd. Open access under CC BY-NC-ND license.
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Fig. 1. (A) Infused computed tomography (CT) scan of the chest showing a moderately enhanced solitary pulmonary tumor in the right upper lobe. (B) The tumor showing
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hositive F-18-ﬂuoro-2-deoxyglucose (FDG) uptake on positron emission tomograp
uperior pulmonary vein encircled with a rubber tape.). (D) Histopathological sect
elanin pigment. (Hematoxylin and eosin; ×200).
xternal beam charged particle radiation therapy, transpupillary
hermotherapy, location tumor resection, and enucleation. Enucle-
tion is the traditional method of treating medium (longitudinal
iameter 2.5–10 mm,  anterior-posterior diameter ≤16 mm)  and
arge (longitudinal diameter ≥10 mm;  anterior-posterior diameter
16 mm)  choroidal melanoma. Irrespective of the availability of
lternative treatment modalities, e.g., plaque radiotherapy, proton
eam radiotherapy, and trans-pupillary thermotherapy, the sur-
ival rates of patients with choroidal melanoma have not changed
n the past 30 years.1 Recently gamma  knife surgery has been also
tudied for its potential, however, its role in treatment has yet to be
lucidated.2 Considering that the success of choroidal melanoma
epends on vision-related quality of life as well as survival and
hat a variety of treatment modalities are available, its therapeutic
trategy should be individualized.2
The cumulative rates of metastases in the Collaborative Ocular
elanoma Study (COMS) at 5 and 10 years after treatment were
5% and 34%, respectively. Common sites of metastases include
iver (90%), lung (24%), and bone (16%).3,4 The report by Lorigan
t al. describes that isolated pulmonary metastases from ocular
elanoma are very rare, accounting for 3.6% of metastatic ocular
elanoma because extra-ocular spread to other organs has almost
lways been seen in association with hepatic metastases.5 Patients
ith metastases conﬁned to extrahepatic locations have longer sur-
ival (19 versus 7 months).6 Aoyama et al. reported longer survival
fter complete surgical removal of metastatic choroidal melanoma
n selected patients, including 2 with a solitary lung nodule.7
There have been reports regarding predictive factors of the
etastatic potential of choroidal melanoma. According to the
OMS classiﬁcation, primary tumor size is one of the best parame-
ers to predict the risk of metastatic disease. Diener-West et al. have
ummarized that the 5-year survival rates after enucleation were
4% for small, 68% for medium-sized, and 47% for large tumors.8 In
ur case, the size of the original choroidal melanoma was  classiﬁed
s large. In terms of TNM cancer classiﬁcation by American joint
ommittee on cancer, our case was staged as T3aN0M0, stage B
ith the 10-year survival rate of 68%.9 Therefore, considering the
igher recurrence rate, it is quite reasonable that the patient hadET) scan. (C) Black tumor around the pulmonary hilum. (Arrow head showing the
 the resected specimen demonstrating metastatic choroidal melanoma containing
seen an ophthalmologist and underwent chest radiography annu-
ally, even though more than 10 years had passed since the primary
ocular lesion was treated. From our experience, patients treated for
choroidal melanoma should be followed up for more than 10 years.
So far, there has been no universally accepted modality of
screening for metastatic choroidal melanoma. In the COMS trial,
chest radiography and liver function tests were performed every 6
months for at least 5 years.3 Klingenstein et al. reported that whole-
body FDG-PET/CT imaging is a sensitive modality in the follow-up
of choroidal melanoma patients though the amount of radiation
exposure from the FDG-PET/CT imaging should be worried about.10
Considering our case in which solitary pulmonary metastasis was
FDG-avid on PET scan, FDG-PET/CT imaging might be a sensitive
modality for detecting metastatic choroidal melanoma. In terms
of screening, the effectiveness of CT scan for metastatic choroidal
melanoma has not been elucidated yet.
4. Conclusion
Choroidal melanoma has the potential to metastasize even after
more than 10 years after treatment of the primary ocular lesion.
Regular long-term follow-up for patients with metastatic choroidal
melanoma is mandatory. If the metastatic lesion is extrahepatic and
resectable, surgery should be the treatment of choice.
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